<p>Multidrug-resistant <i>Klebsiella pneumoniae</i> requires alternative therapies. In this study, we characterized two novel phages, PKP K9 (a siphovirus) and PKP Kh11 (a myovirus). Both showed genomic safety and exhibited excellent reproduction and physicochemical tolerance. A cocktail containing both phages had a broad combined host range (85.7%, 72/84) and showed potent <i>in vitro</i> activity with distinct dose-dependent inhibition modes. In a <i>Galleria mellonella</i> infection model, each phage individually and the two combined provided complete prophylactic and therapeutic protection against lethal challenge. The PKP K9/PKP Kh11 cocktail demonstrates significant therapeutic potential against multidrug-resistant <i>K. pneumoniae</i>.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Phage-cocktail-based biocontrol of multidrug-resistant Klebsiella pneumoniae both in vitro and in vivo

  • Ling Zou,
  • Yang Yu,
  • Dongxue Yue,
  • Chuanxu Wang,
  • Shijie Xu,
  • Wenhua Liu,
  • Shouzhen Xu,
  • Jing Ma,
  • Hong-Bo Ni,
  • Tao He,
  • Ran Wang,
  • Yehui Sun,
  • Can Zhang

摘要

Multidrug-resistant Klebsiella pneumoniae requires alternative therapies. In this study, we characterized two novel phages, PKP K9 (a siphovirus) and PKP Kh11 (a myovirus). Both showed genomic safety and exhibited excellent reproduction and physicochemical tolerance. A cocktail containing both phages had a broad combined host range (85.7%, 72/84) and showed potent in vitro activity with distinct dose-dependent inhibition modes. In a Galleria mellonella infection model, each phage individually and the two combined provided complete prophylactic and therapeutic protection against lethal challenge. The PKP K9/PKP Kh11 cocktail demonstrates significant therapeutic potential against multidrug-resistant K. pneumoniae.